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Abstract
Objectives
Employment status is a major predictor of health status and living conditions, especially among HIV-infected people, a
predominantly working-aged population. We aimed to quantify the risk of work cessation following HIV diagnosis in France in 2004–
2010 and to measure the respective burden of HIV-related characteristics and of associated comorbidities on this risk.
Design
We used data from the ANRS-COPANA multicenter cohort made of a diversified sample of recently diagnosed HIV-1-infected adults,
antiretroviral treatment-na ve at baseline in 2004 2008. Detailed information on living conditions and clinical and biologicalï –
characteristics were collected prospectively.
Methods
The risk of work cessation among the 376 working-aged participants employed at baseline was estimated using the Kaplan-Meier
method. Characteristics associated with the risk of work cessation were identified using multivariate Cox models.
Results
The cumulative probability of work cessation reached 14.1  after 2 years and 34.7  after 5 years. Diabetes, hypertension and, to a% %
lesser extent, signs of depression were associated with increased risks of work cessation after accounting for socio-occupational
characteristics (adjusted hazard ratios 95  confidence interval :5.7 1.7 18.8 , 3.1 1.5 6.4  and 1.6 0.9 2.9 , respectively). In contrast,[ % ] [ – ] [ – ] [ – ]
HIV disease severity and treatment, and experience of HIV-related discrimination were not statistically associated with the risk of
work cessation.
Conclusions
The risk of work cessation during the course of HIV disease has remained substantial in the most recent period in France.
Comorbidities, but not characteristics of HIV disease itself, substantially affect chances of maintaining in employment. This provides
insights into strategies for limiting the burden of HIV disease for individuals and society.
MESH Keywords Adult ; Anti-HIV Agents ; therapeutic use ; Cardiovascular Diseases ; drug therapy ; epidemiology ; virology ; Cohort Studies ; Comorbidity ; Cost of
Illness ; Depression ; drug therapy ; epidemiology ; virology ; Diabetes Mellitus ; drug therapy ; epidemiology ; virology ; Employment ; statistics & numerical data ; Female ; 
France ; HIV Infections ; drug therapy ; epidemiology ; virology ; HIV-1 ; Health Status ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Occupational Health ; 
Proportional Hazards Models ; Prospective Studies ; Socioeconomic Factors ; Truth Disclosure
Author Keywords Employment status ; Socioeconomic factors ; Comorbidity ; HIV-related discrimination ; France
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Introduction
Employment is a major factor in maintaining income levels and living conditions, especially among persons with long-lasting chronic
diseases 1 . In addition, unemployment has been shown to be an independent predictor of morbidity and mortality both in the general[ ]
population 2 6  and among HIV-infected people 7, 8 .[ – ] [ ]
Several studies have shown evidence of adverse effects on employment status of various chronic conditions including diabetes 9 11 ,[ – ]
cardiovascular disease 12 14 , cancer 15 18  or depression 19, 20 . As regard to HIV infection, few studies have investigated this topic.[ – ] [ – ] [ ]
They have shown a phenomenon of employment loss occurring from the very first months following disease onset 21 24 . These reports,[ – ]
based on data collected earlier in the era of combined antiretroviral therapies (cART), i.e. in the years 1996 2004, found that HIV infection–
weighted on the chances of maintaining in employment through various mechanisms including disease severity and experiences of
HIV-related discrimination.
Since 1996, the sustained use of cART has resulted in a marked decrease in overall and HIV-related morbidity and mortality among
HIV-infected people. At the same time, the relative burden of comorbidities on health status has dramatically increased 25, 26 .As a result,[ ]
the impact of HIV infection on employment may have changed, as well as the respective burden of HIV disease itself and of comorbidities
on chances of maintaining in employment. Given the importance of employment issues among HIV-infected people, a predominantly
working-aged population, such changes are important to be documented in order to be accounted for in the implementation of
comprehensive care programs. However, data on the topic have remained scarce. The present study aimed at investigating the phenomenon
of work cessation during the course of HIV disease in the recent context in France. More specifically, our objectives were to estimate the
frequency of work cessation among participants of the ANRS-COPANA cohort followed since HIV diagnosis, and to measure the




The French ANRS-C09-COPANA cohort is an ongoing prospective study conducted in 37 hospitals located all over the French
territory. The cohort is made of 800 recently diagnosed (<1 year) HIV-1-infected adults, na ve of antiretroviral treatment at baseline. In theï
participating centres, participants have been enrolled between April 2004 and May 2008 and followed semi-annually through hospital
outpatient visits thereafter. At enrolment and at each scheduled visit, detailed clinical and biological data on characteristics of HIV
infection and its management, associated comorbidities, hospitalizations and health behaviours are collected through a
physician-administered standard questionnaire. In addition, at enrolment and each year thereafter patients are asked to answer a
self-administered questionnaire including detailed information on the various dimensions of their living conditions and depressive
symptoms as measured by the French version of the Center for Epidemiologic Studies-Depression Scale (CES-D) 27 .[ ]
The Paris-Cochin Ethics Committee approved the study protocol and all the participants gave their written informed consent to
participate.
Variables of interest
Employment status at baseline and at each yearly follow-up was obtained from the self-administered questionnaire and categorized as
follows: employed/unemployed/inactive (including participants retired, on disability or long-term (>1 year) sick leave, students and house
workers). Work cessation was defined as moving from employment to either unemployment or inactivity before reaching the legal age of
retirement in France, i.e. 60 years old. The date of work cessation corresponded to the date of beginning of unemployment or inactivity as
reported in the self-administered questionnaire.
Sociodemographic characteristics including age, gender and educational level were collected at enrolment through the physician
questionnaire, in addition to HIV transmission category. Nationality, country of birth and age at arrival in France were documented in the
baseline self-questionnaire. Participants born outside of France were considered as migrants if they did not have the French nationality or,
for those with the French nationality, if they arrived in France when they were older than 15 years. For those employed, occupational
characteristics including occupational grade and job status were self-reported at baseline and during follow-up. Indicators of living
conditions including cohabiting partnership, disclosure of HIV serostatus in close relationships (partner, family members, friends,
colleague) and experience of HIV-related discrimination in the preceding year were also documented in the baseline and follow-up
self-questionnaires.
Health status characteristics documented by the physician at each visit included indicators of HIV disease advancement and
management (date of diagnosis, stage B or C defining illnesssince the last cohort visit, CD4 cell count, HIV viral load, cART prescription)
and indicators of comorbidities. These included: history of diabetes and cardiovascular disease; coinfection with Hepatitis B virus (HBV)
HIV disease, comorbidityand employment
AIDS . Author manuscript
Page /3 11
as defined by the presence of hepatitis-B surface antigens (HBsAg) or e antigens (HBeAg); coinfection with Hepatitis C virus (HCV) as
defined by a positive HCV PCR; and hypertension as defined by the prescription of an antihypertensive treatment. The presence of
symptoms of depression in the preceding week was assessed by a CES-D score above 17 for men and 23 for women, the optimal cut-off
scores identified in the French population Fuhrer, 1989 46 . At each follow-up visit the physician also reported hospitalizations having{ # }
occurred since the last cohort visit, injecting drug use (IDU) and alcohol consumption.
Statistical analysis
Analyses were restricted to participants who were of working age (i.e., <60 years) at baseline, whether they were employed,
unemployed or inactive. Moreover, to be included participants had to have attended at least the month 12 visit at the cut-off point of 30
June 2010. The risk of work cessation over time since enrolment among participants employed at baseline was estimated using the
Kaplan-Meier method(1 minus Survival). Characteristics associated with the risk of work cessation were identified using univariate and
multivariate Cox models. Both fixed and time-dependent variables were included in the models. Fixed variables included gender, age,
migrant status, educational level, job status and HBV or HCV coinfection (as reported at baseline).Time-dependent variables included
cohabiting partnership, disclosure of HIV serostatus, experience of HIV-related discrimination in the preceding year, stage B or C defining
illness in the preceding 6 months, CD4 cell count, viral load, cART prescription, diabetes, hypertension, symptoms of depression in the
preceding week and hospitalization in the preceding 6 months. For all these time-dependent covariates, we considered the value reported at
the preceding visit. In the univariate step, associations of sociodemographic, occupational, living conditions, health status and health
behaviours characteristics with the risk of work cessation were measured. All variables associated with the risk of work cessation with a
p-value<20  in univariate analysis were included in the multivariate model.%
Statistical analyses were performed using SAS 9.2.
Results
Sample characteristics
A total of 622 participants were included. Among them, 376 (60.4 ) were employed at baseline and thus constituted the population at%
risk of employment loss in our study. As of 30 June 2010, these 376 participants had been followed during a median time of 37.0 months
(IQR 24.8 to 53.2) and had attended a median of 6 semi-annual scheduled outpatient visits after enrolment. Therefore, at the cut-off point
time, all of them had attended the month 12 (M12) visit, 327 had attended the M24 visit, 217 the M36 visit, 134 the M48 visit, 67 the M60
visit and 20 the M72 visit.
The 622 participants constituted a diversified sample of HIV-infected patients, with 29.9 women and40.5  migrants (58.4% % %
originating from sub-Saharan Africa). The majority had been HIV-infected through homo/bisexual (44.5 ) or heterosexual (44.2 )% %
contacts. Only 5participants reported having ever used injecting drugs. As shown in Table 1, women and migrants were under represented
in the subgroup of participants employed at the time of enrollment in the cohort (19.2 versus 46.3  and23.7 versus 66.3 , respectively).% %
Compared to participants without employment, the 376 employed participants were also older (median age 36 versus 33 years,
respectively) and more educated (91.2  with more than elementary or middle school level versus 68.7 , respectively). In majority, they% %
were employed as clerks or associate professionals or technicians (61.7 ) and held a permanent salaried position (71.6 ). In addition,% %
compared to participants without employment, those employed at baseline were more likely to live with a partner (57.7  versus 51.2 ,% %
respectively) and to have disclosed their HIV serostatus to their close circle of family, friends or colleagues (78.7  versus 58.5 ,% %
respectively). Only a minority in both groups reported having ever experienced HIV-related discrimination at enrolment.
Overall, median time between HIV diagnosis and the first cohort visit was 4.5 months (4.5 and 4.3 months, respectively, among
participants with and without employment at baseline). At their first visit, employed participants were significantly less likely than those
without employment to have full-blown AIDS (5.1  versus 10.6 , respectively),severe immunosuppression with a CD4 cell count of less% %
than 200/mm (15.4  versus 23.2 , respectively) or a viral load higher than 5log copies/mL (21.5  versus 29.8 , respectively).They3 % % 10 % %
were also less likely to have HBV or HCV coinfection (2.4  versus 8.9 , respectively) and symptoms of depression (31.6  versus 42.7% % % %
, respectively).Overall, 32.6  of participants initiated cART within the 3 months following enrolment.%
Work cessation
Overall, among the 376 participants employed at baseline, 67 stopped working before they reached the age of 60 years: 58 became
unemployed, 4 retired, 3 left on long-term sick leave, and 2 went back to training. Work cessation occurred after a median follow-up time
of 20.3 months (IQR 10.2 to 33.9). The cumulative probability of work cessation reached 5.4  (95  confidence interval CI  3.0 to 7.6 )% % [ ] [ %]
at M12, 14.1 10.2 to 17.8  at M24, 18.7 13.9 to 23.2  at M36, 23.1 17.3 to 28.5  at M48 and 34.7 24.0 to 43.9  at M60.%[ %] %[ %] %[ %] %[ %]
Among the 67 participants who experienced work cessation, 24 (35.8 ) subsequently returned to work during follow-up. Return to%
work occurred within a median time of 11.5 months (IQR 8.0 to 16.3) after cessation of the previous work. At the cut-off point time, 20 of
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these 24 were still employed. Thus, of the 376 participants employed at baseline, a total of 47 (12.5 ) were still out of employment at the%
end of follow-up.
Factors associated with the risk of work cessation over time
As shown in Table 2, in multivariate analysis the risk of work cessation was associated with individuals  sociodemographic and’
occupational characteristics: participants aged 30 39 years had a higher risk of work cessation compared to those aged 40 49 years– –
(adjusted Hazard Ratio aHR  3.1, 95  CI 1.5 to 6.5 ). The risk of work cessation was also higher in participants with a primary level of[ ] % [ ]
education (aHR 2.6 1.0 to 6.7 ) and, to a lesser extent, in those with a technical education (aHR 2.1 0.9 to 5.1 ) compared to participants[ ] [ ]
who attended college or university. In addition, job status was associated with the risk of work cessation, those being self-employed (aHR
6.1 1.7 to 21.7 ), holding a temporary job contract (aHR 8.8 3.1 to 24.8 ) or holding a permanent position in the private sector (aHR 2.8 [ ] [ ] [
1.1 to 7.6 ) experiencing a higher frequency of work cessation compared to those holding a permanent position in the public sector.]
Participants living on their own also tended to stop their work more frequently than those living with a partner (aHR 1.6 0.9 to 2.9 ).[ ]
Women and migrants were at a higher risk of work cessation in univariate analysis; though, these associations were no longer significant
after adjustment for educational level and employment status.
Accounting for sociodemographic and occupational characteristics, the risk of work cessation was significantly higher among
participants with diabetes (aHR 5.6 1.7 to 18.5 ) and among those with hypertension (aHR 3.1 1.5 to 6.4 ) compared to those free of these[ ] [ ]
comorbidities. Symptoms of depression also tended to be associated with an increased risk of work cessation (aHR 1.7 0.9 to 2.9 ). In[ ]
contrast, HIV disease severity, as measured either clinically (i.e. occurrence of a stage B or C defining illness in the preceding 6 months)
or biologically (i.e. CD4 cell count <350/mm or viral load 5log copies/mL), was not associated with a significant increase in the risk of3 ≥ 10 
work cessation. Experience of HIV-related discrimination was not statistically associated with the risk of work cessation either, nor was
cART prescription or hepatitis coinfection.
Sensitivity analysis
Predictors of work cessation may be different according to various factors including individuals  willingness to maintain in’
employment and the type of work contract (permanent vs. temporary). To estimate the impact of these differences on our results we
performed two sensitivity analyses: 1)censoring work cessations that are likely to have been chosen, i.e. those followed by a return to
training or by retirement; 2) excluding individuals with a temporary job contract for whom work cessation was likely to result from the
termination of their contract. In both analyses, diabetes and hypertension remained associated with an increased risk of work cessation.
Furthermore, the associations between indicators of HIV disease severity and work cessation remained non-significant.
Discussion
HIV infection most often occurs in early adulthood, and the majority of HIV-infected individuals are of working age. Therefore,
employment constitutes a major dimension in the life of HIV-infected people, and understanding the ways by which the disease interferes
with employment may provide insights into strategies for limiting the burden of HIV disease for individuals and society. This requires the
availability of longitudinal datasets documenting both clinical, biological and socio-occupational aspects. Information on
socio-occupational characteristics are generally not routinely collected in hospital databases; as a result, studies on the impact of HIV
infection on employment have remained limited in the recent period, despite the dramatic changes having occurred regarding the course of
the disease. To our knowledge, our study is the first to prospectively document this major issue in the current context of sustained use of
cART.
Our results provide evidence for the existence of a phenomenon of work cessation starting from the very first months following HIV
diagnosis and persisting during the five subsequent years in the current context in France, suggesting substantial social and economic
consequences for patients, employers and society. Accounting for individuals  sociodemographic and occupational characteristics, HIV’
disease advancement and treatment, and self-reported experience of HIV-related discrimination do not appear to be significant predictors
of work cessation. In contrast, comorbidities frequently associated with HIV disease including diabetes, hypertension and depression
substantially affect the chances of maintaining in employment during the course of HIV infection.
The ANRS-COPANA cohort constitutes a unique source of information to appropriately investigate the social aspects of HIV
infection. Indeed, information collected prospectively from the early time of HIV diagnosis includes detailed data both on social,
occupational and health characteristics. In addition, the cohort is made of a diversified sample of HIV-infected patients: overall, women
account for 30  of the participants, migrants (mostly from Sub-Saharan Africa) for 41 , and MSM for 64 . Such diversity suggests that% % %
the ANRS-COPANA cohort provides insights into the situation of the different socially contrasted subgroups of patients encountered in
France as in many other European settings. The employment rate at baseline in the whole cohort (62.9 ) was close to the rate of 59.3% %
estimated among people diagnosed HIV-infected in France in 1994 2003 in the ANRS-VESPA survey 28 , suggesting that the study– [ ]
population also provides a good reflect of the employment situation of HIV-infected people in France. The longitudinal design of the
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ANRS-COPANA cohort allowed us to consider covariates as time-dependent variables, thus accounting for underlying dynamic processes.
Covariates were systematically measured previous work cessation (at baseline or at the time of the preceding visit), suggesting that the
associations we show are unlikely to reflect reverse causality or contemporaneity. However, it must be acknowledged that, as in any single
observational study, causality cannot definitely be established.
Our results indicate that the risk of work cessation during the course of HIV infection has remained substantial in the recent period in
France, with more than one third (34.7 ) of patients having ended the job they held at the time of HIV diagnosis after five years. A%
previous study showed that in France, employment rate was lower in HIV-infected people than in the general population, probably as a
result of decreased chances of maintaining in employment for the former 28 . In the present study the extent to which the rate of work[ ]
cessation was higher than in the general population, reflecting the overall burden of HIV infection on work cessation, could not be
examined. Only a formal comparison to the frequency of work cessation during the same time period in HIV-uninfected people with
comparable positions on the labor market would allow the quantification of this burden.
Although substantial, the rate of work cessation in our study appears lower than reported earlier in the cART era in France. Indeed, in
our study 12.5  of patients initially employed were out of employment almost 3 years after HIV diagnosis; this proportion was twice%
higher (25.0 ) among participants of the ANRS-PRIMO cohort employed at the time of enrolment in 1996 2002, although they had been% –
enrolled an earlier stage of the disease, i.e. primary HIV infection, and followed during a shorter time (2.5 years in median) 21 .In[ ]
addition, data from the ANRS-VESPA survey showed that among people diagnosed HIV-infected in France in 1996 2002 while they were–
employed, 32.4 had lost their employment 4 years later 22 . Some cases of work cessation might have been underreported in the% [ ]
ANRS-COPANA database. This is particularly the case for episodes of work cessation occurred early in the course of HIV infection, i.e.
previous enrolment in the cohort, and for those of short duration. However, similar sources of underestimation might have biased estimates
of work cessation rates in previous studies as well; thus, the lower frequency of work cessation we report is likely to reflect an actual
decreasing burden of HIV disease on work cessation with the sustained use of cART.
Our results do not provide evidence for a significant role of HIV-related characteristics on the risk of work cessation in the current
context in France. This finding is consistent with a recent study showing that employment status was not associated with the level of CD4
cell count among HIV-infected outpatients followed in 2008 2009 in the UK 29 . In contrast, HIV disease severity and reported– [ ]
experience of HIV-related discrimination were found to be significant predictors of work cessation earlier in the cART era 21 24 . Such a[ – ]
discrepancy is likely to reflect changing barriers and attitudes to continued employment during the course of HIV disease in the most
recent period. Of note, in the present study we focused on the termination of the job held at the time of enrolment in the cohort. Thus, our
results pertain to HIV-infected patients employed at the time of HIV diagnosis, a subgroup more privileged than those out of employment
as regard to position on the labor market (i.e., more likely to be middle-aged educated French-native men), HIV disease severity and
comorbidity. Although we did not find any significant role of HIV disease characteristics on the risk of work cessation in this specific
subgroup of patients employed at baseline, the existence of a significant impact of these characteristics on employment status of patients
unemployed at the time of HIV diagnosis cannot be ruled out. Future studies need to investigate the determinants of access to and maintain
in employment during the course of HIV disease among patients unemployed at the time of HIV diagnosis.
Physical and mental health impairments related to longstanding illnesses such as cardiovascular disease, diabetes or depression are
known to be significant predictors of unemployment in the general population 19, 20, 30, 31 . In a previous study, such chronic conditions[ ]
have also been found to weight on the chances of maintaining in employment among HIV-infected people, independently of HIV disease
characteristics 21 . Here we found that unlike HIV disease severity and reported experience of HIV-related discrimination, comorbidities[ ]
including diabetes, hypertension and symptoms of depression were associated with an increased risk of work cessation during the course of
HIV infection. This suggests that comorbidities constitute major barriers to continued employment among HIV-infected people in the
current context in France,.
Employment discontinuation during the course of HIV infection may result from various pathways. Physical and mental functioning,
workplace discrimination, difficulties to combine job demands in addition to disease management may directly weight on the chances of
maintaining in employment, resulting in involuntary work cessations. Such involuntary work cessations may also result from
non-health-related factors, e.g. the termination of a temporary work contract. On the other hand, employment discontinuation may result
from a reasoned choice of leaving employment, e.g. for people who wish to go back to training or to retire or for those who can afford to
live on their partner s (or other supportive person s) income. In our study, back to training and retirement only accounted for 6 of the 67’ ’
work cessations; furthermore, living with a partner tended to be associated with a decreased risk of work cessation. This suggests that this
phenomenon of planned work cessation is probably limited. Moreover, sensitivity analyses showed that the burden of HIV-related
characteristics and comorbidities on the chances of maintaining in employment remained unchanged when potentially planned work
cessations were censored and individuals with a temporary work contract were excluded, thus supporting our results.
In conclusion, the present study provides evidence that the risk of work cessation during the course of HIV infection has remained
substantial in the most recent period in France. Social and economic consequences for patients, employers and society are likely to be
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important and should be addressed at different levels including clinical settings, employers and social workers. A particular attention
should be paid to prevent HIV-infected patients affected by comorbidities from leaving employment.
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Table 1
Baseline characteristics of participants with and without employment at the time of enrollment in the cohort
Employment status at baseline
paWith Employment (N 376)= Without Employment (N 246)=
# % # %
Age
 <30 years 82 21.8 82 33.3 <0.01
 30 39 years– 149 39.6 103 41.9
 40 49 years– 104 27.7 40 16.3
 50 59 years– 41 10.9 21 8.5
Women 72 19.2 114 46.3 <0.01
Migrants 89 23.7 163 66.3 <0.01
Educational level
 Elementary or Middle school 33 8.8 77 31.3 <0.01
 Trade school 82 21.8 32 13.0
 High school 75 20.0 49 19.9
 College or University 181 48.1 81 32.9
 Missing 5 1.3 7 2.9
Occupational grade
 Managers, Craftsmen 22 5.9 - - -
 Executive 56 14.9 - -
 Associate professionals or technicians 103 27.4 - -
 Clerks 129 34.3 - -
 Manual workers, Farmers 64 17.1 - -
 Missing 2 0.5 - -
Job status
 Self-employed 34 9.0 - - -
 Permanent contract, public sector 86 22.9 - -
 Permanent contract, private sector 183 48.7 - -
 Temporary contract 73 19.4 - -
Cohabiting partnership 217 57.7 126 51.2 <0.01
HIV status kept secret 80 21.3 102 41.5 <0.01
Experience of HIV-related discrimination 29 7.7 25 10.2 0.29
Clinical stage
 A 337 89.6 212 86.2 0.02
 B 19 5.1 8 3.3
 C 19 5.1 26 10.6
CD4 cell count (/mm )3 
 <200 58 15.4 57 23.2 <0.01
 200 349– 78 20.7 66 26.8
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 350 499– 117 31.1 55 22.4
 ≥500 123 32.7 68 27.6
Viral load (log copies/mL)10 
 <5 293 78.6 172 70.2 0.02
 ≥5 80 21.5 73 29.8
HBV or HCV coinfection 9 2.4 22 8.9 <0.01
Diabetes 8 2.1 3 1.2 0.54
Hypertension 26 6.9 14 5.7 0.54
Symptoms of depressionb 119 31.6 105 42.7 <0.01
a Chi test or Fisher s exact test as appropriate2 ’
b CES-D score above 17 for men and 23 for women
Table 2
Characteristics associated with the risk of work cessation among the 376 participants employed at baseline
# with work cessation
Univariate Multivariate
HR 95  CI[ % ] HR 95  CI[ % ] pa
Genderb
 Women 19 1.7 1.0 2.9[ – ] 1.1 0.6 2.2[ – ] 0.77
 Men 48 1 1 -
Ageb
 <30 years 11 1.2 0.5 2.5[ – ] 1.8 0.7 4.5[ – ] 0.22
 30 39 years– 32 1.8 0.9 3.3[ – ] 3.1 1.5 6.5[ – ] 0.003
 40 49 years– 14 1 1 -
 50 59 years– 10 2.5 1.1 5.5[ – ] 1.9 0.8 4.7[ – ] 0.14
Migrantb
 Yes 24 1.9 1.1 3.1[ – ] 1.3 0.6 2.6[ – ] 0.48
 No 43 1 1 -
Educational levelb
 Primary school 11 2.6 1.3 5.3[ – ] 2.6 1.0 6.7[ – ] 0.05
 Trade school 15 1.4 0.7 2.5[ – ] 2.1 0.9 5.1[ – ] 0.08
 High school 14 1.4 0.7 2.6[ – ] 1.3 0.6 2.9[ – ] 0.45
 College or University 27 1 1 -
 Missing 0 - - -
Job statusb
 Self-employed 9 5.2 1.8 15.6[ – ] 6.1 1.7 21.7[ – ] 0.005
 Permanent contract, public sector 5 1 1 -
 Permanent contract, private sector 26 2.4 0.9 6.2[ – ] 2.8 1.1 7.6[ – ] 0.04
 Temporary contract 27 8.1 3.1 21.1[ – ] 8.8 3.1 24.8[ – ] <0.001
Cohabiting partnershipc
 No 35 1.7 1.0 2.7[ – ] 1.6 0.9 2.9[ – ] 0.09
 Yes 30 1 1 -
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 Missing 2 0.8 0.2 3.6[ – ] 0.9 0.2 3.9[ – ] 0.89
HIV status kept secretc
 Yes 15 2.7 1.5 5.0[ – ] 1.6 0.8 3.4[ – ] 0.21
 No 52 1 1 -
Experience of HIV-related discrimination in the preceding yearc
 Yes 8 1.7 0.8 3.6[ – ] 1.6 0.7 3.6[ – ] 0.26
 No 59 1 1 -
Stage B or C defining illness in the preceding 6 months c
 Yes 4 2.2 0.8 6.2[ – ] 1.3 0.4 4.3[ – ] 0.67
 No 63 1 1 -
CD4 cell countc
 <350/mm3 22 1.4 0.8 2.3[ – ] 1.4 0.8 2.4[ – ] 0.24
 ≥ 350/mm3 45 1 1 -
Viral load (log copies/mL)c10 
 ≥5 6 1.1 0.5 2.7[ – ] - -
 <5 61 1 - -
Prescription of cARTc
 Yes 28 0.8 0.5 1.3[ – ] - -
 No 39 1 - -
HBV or HCV coinfectionb
 Yes 1 1.3 0.2 9.8[ – ] - -
 No 66 1 - -
Diabetesc
 Yes 4 4.3 1.6 11.9[ – ] 5.6 1.7 18.5[ – ] 0.005
 No 63 1 1 -
Hypertensionc
 Yes 14 2.4 1.3 4.4[ – ] 3.1 1.5 6.4[ – ] 0.002
 No 53 1 1 -
Symptoms of depression in the preceding weekc, d
 Yes 23 1.5 0.9 2.5[ – ] 1.7 0.9 2.9[ – ] 0.07
 No 44 1 1 -
Hospitalization in the preceding 6 months c
 Yes 7 2.2 1.0 4.9[ – ] 1.1 0.4 2.9[ – ] 0.84
 No 60 1 1 -
HR Hazard Ratio; CI Confidence Interval
a Cox model adjusted for gender, age, migrant status, educational level, job status, cohabiting partnership, HIV-related discrimination, stage B or C defining illness, CD4 cell count, diabetes,
hypertension, symptoms of depression and hospitalization
b As reported at baseline(fixed)
c As reported at the preceding visit(time-dependent)
d CES-D score above 17 for men and 23 for women
